Jenburkt Pharma
Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2026.
Filed with BSE · ISIN INE354A01013 ·
6ix is reading this filing.
View original source (BSE India)Jenburkt Pharmaceuticals Ltd on 6ix
Earlier from Jenburkt Pharmaceuticals
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Jenburkt Pharmaceuticals Ltd Press Release Sep 04 2026
- Jenburkt Pharmaceuticals Ltd Press Release Aug 07 2026
- Jenburkt Pharmaceuticals Ltd Press Release Aug 04 2026
Follow Jenburkt Pharmaceuticals into a list and get an email when it puts out news.
Follow Jenburkt Pharmaceuticals